Project Elevator Pitch
Confidential · For registered investors
Issued
2026-06-04
CMA
Belize · Clinics/Hospitals
Medical Campus & Resort | Belize
Clinics/Hospitals
Healthcare
Hospitality
Hotels/Resorts
Leisure/Recreation
Capital Sought
USD 243,000,000
Spent to date
USD 3,000,000
Country
Belize
Repayment
Independent and credible feasibility study
Submission Ready Indicators
LTV Expectation
100%
Land / Site
Sale/lease agreed
EPC Contracts
Signed
Off-take Agreements
Draft form
Projections
Completed and available
This opportunity qualifies for Internationally A+-rated Insurance Wrap — elevating the debt element of project financing through the Lloyds-of-London insurance market.
About this opportunity
CMA is a unique, planned Medical facility to be located in Belize that will combine state-of-the-art medical procedures along with a medical and tourism hospitality campus.
Located on the northeastern shore of Belize, CMA will bring together the highly profitable traditional health care industry with medical spa medical tourism and offer a complete package that includes cardiac care, gastric surgeries, joint replacement, and stem cell therapy, treatment for degenerative disease, cosmetic surgeries, education, and practice of fundamental health principals.
There are five main facilities that will make up the Medical Campus: 350 bed Hospital Facility, Medical Tourism Center; Longevity Center; Medical Spa; and Research & Design Lab.
The campus and hospital will be staffed by fully-accredited physicians and support staff.
CMA requires financing in the amount of $243M (USD) to complete construction of the hospital and to renovate existing hospitality venues.
CMA shows strong earnings potential and excellent EBITDA projections from year five and onward.
Belize is an excellent destination as it provides ease-of- travel from N. America, Europe, etc., with a multitude of airlines already serving a thriving tourist industry.
Five-year projections
All figures in USD| USD | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Turnover | 12,749,605 | 13,480,590 | 47,728,230 | 60,248,931 | 72,025,457 |
| EBITDA | 35,346,840 | 39,096,840 | 107,350,946 | 119,576,916 | 162,037,024 |
| Margin % | 63.93 | 65.52 | 55.54 | 49.19 | 55.55 |
Ready to learn more?
The full executive summary and data room are available to PFX registered investors.
Register as Investor
Executive summaries can be viewed by registered PFX Investors. Already registered? Sign in.
Confidential — PFX Registered Investors Only · Not for redistribution
PFX / CMA / 2026-06-04